logo
ProjectActive

Medgenome

Sector: Warehouse • Location: India

Source: International Finance Corporation (IFC)

MedGenome Inc. (the “Company”), is a USA incorporated genetic diagnostics, research, and data licensing enterprise. It has a corporate office in Foster City, California. The Company established its Indian operations - MedGenome Laboratories Limited (MLL) - at Bengaluru in the year 2013; and is active in genomics and clinical data driven diagnostics and research with a focus on next generation sequ

Status
Prospective
Sector
Warehouse, Residential, Commercial, Telecommunications, Government
Location
India
Updated
19 Nov 2026
Source
International Finance Corporation (IFC)

ConstructChat

Ask ConstructChat about Medgenome

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “Medgenome” is an infrastructure initiative in the Warehouse sector, located in India. Taiyo aggregates data on it from International Finance Corporation (IFC).

Participants

Sponsoring Agency

Status

Original status

active

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

MedGenome Inc. (the “Company”), is a USA incorporated genetic diagnostics, research, and data licensing enterprise. It has a corporate office in Foster City, California. The Company established its Indian operations - MedGenome Laboratories Limited (MLL) - at Bengaluru in the year 2013; and is active in genomics and clinical data driven diagnostics and research with a focus on next generation sequencing (NGS).The Company had set-up a full-fledged genetics and diagnostics laboratory facility in Bengaluru, which offers genetic testing, genome sequencing, molecular diagnostics, and related services. The Company has set-up small satellite labs in other locations such as Mumbai, Cochin, Hyderabad etc. The diagnostic samples collected from customers/patients through its network of 1600+ hospitals and 5500+ clinicians in India are received at its lab facilities through third party commercial logistic service providers. The Company offers 475+ genetic tests across several disease categories such as paediatrics, neurology, oncology, haematology, endocrinology, nephrology, ophthalmology, etc. The proposed IFC investment in the Company involves preferred equity investment of up to US$16.5 million. IFC investment is to be deployed to build capacities and capabilities in: 1) developing diagnostics business unit (BU) operations such as: (i) geographic expansion to neighbouring countries around India (ii) screening and direct to consumer (DTC) test launch and (iv) small acquisitions and partnerships; and 2) developing Research and Data BU operations such as: (i) enriching SARGAM (South Asia Research Genotyping Array) Biobank; (ii) building informatics infrastructure; and (iii) enhancing disease specific deep data sets (the “Project”).

Original sector

other

Location

Country

India

Source

Source

International Finance Corporation (IFC)

URL

More Details

Record type

Project

Sector

Warehouse, Residential, Commercial, Telecommunications, Government

Article published date

2025-08-08

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project